Angiogenesis in epithelian ovarian cancer
- PMID: 12456770
- PMCID: PMC1187269
- DOI: 10.1136/mp.55.6.348
Angiogenesis in epithelian ovarian cancer
Abstract
Angiogenesis, the development of new blood vessels from the existing vasculature, is an essential component of solid tumour growth and metastasis. Several angiogenic factors are expressed by many tumours, suggesting that tumours promote their own vascularisation by activating the host endothelium. This review will discuss various angiogenic stimulators and inhibitors in epithelian ovarian cancer (EOC), including vascular endothelial growth factor and platelet derived endothelial cell growth factor/thymidine phosphorylase. The analysis of tumour vascularisation by microvessel density will also be discussed and the relevance of these markers of angiogenesis in the prognosis of EOC will be assessed.
Figures
References
-
- Czernobilsky B. Common epithelial tumors of the ovary. Blaustein’s pathology of the female genital tract, RJ Kurman, ed. New York: Springer-Verlag, 1987.
-
- Kristensen GB, Trope C. Epithelian ovarian carcinoma. Lancet 1997;349:113–17. - PubMed
-
- Land A. Ovulation, ovulation induction and ovarian carcinoma. Ballieres Clin Obstet Gynaecol 1993;7:455. - PubMed
-
- Russell P, Bannatyne P. Surgical pathology of the ovaries, Appendix B. Edinburgh: Churchill Livingstone, 1989.
-
- Serove S, Sculy R, Sobin L. The molecular pathogenesis of ovarian cancer. In: International histological classification of tumours. No. 9: Histological typing of ovarian tumours. Geneva: World Health Organisation, 1973:46–50.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical